Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Pharma Antibiotic OK’d for Trial

publication date: Oct 29, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Pharma Holdings was given the go-ahead by the SFDA to begin clinical trials of a novel antibiotic combination formula. China Pharma describes the new product as a third generation Cephalosporin antibiotic combined with a bacterial-enzyme inhibitor. Its clinical trial will begin in November. The complete run of clinical trials will take two years, according to the company.  More details...

Stock Symbol: (OTCBB: CPHI) 


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...